Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS29P1 (ribosomal protein S29 pseudogene 1) is a processed pseudogene related to the functional ribosomal protein S29 (RPS29) gene. Pseudogenes like RPS29P1 are DNA sequences that arise from the duplication or retrotransposition of a functional gene but have lost the ability to encode a functional protein, typically due to mutations or truncations. RPS29P1 does not encode a structural or regulatory protein and is not known to have any function in humans[4][6]. It should not be confused with the functional RPS29 gene, which encodes a component of the 40S small ribosomal subunit essential for protein synthesis and implicated in Diamond-Blackfan anemia[1][2][3][5][7]. Key point: RPS29P1 is a pseudogene, not a protein-coding gene and not a therapeutic target; all functional or disease information pertains to RPS29, not the pseudogene[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein S29 pseudogene 1 (RPS29P1).